Table 3.
Seventeen-week supplementation with krill oil relative to baseline
| Measure | Baseline Mean±SD |
Krill oil Mean±SD |
p Value |
|---|---|---|---|
| EndoPAT (RHI) | 1.90±0.54 | 2.16±0.73 | 0.041* |
| HbA1c (%) | 7.5±1.1 | 7.4±1.2 | 0.388 |
| TC (mg/dL) | 146.38±29.04 | 152.56±27.41 | 0.242 |
| HDL (mg/dL) | 43.48±14.10 | 49.09±15.63 | 0.002* |
| Triglycerides (mg/dL) | 148.18±96.35 | 144.82±73.79 | 0.815 |
| LDL (mg/dL) | 76.64±27.70 | 75.04±23.82 | 0.754 |
| Non-HDL (mg/dL) | 103.97±30.39 | 104±29.01 | 0.995 |
| TC/HDL | 3.57±1.15 | 3.31±1.11 | 0.166 |
| Glucose (mg/dL) | 141.60±42.89 | 139.58±43.44 | 0.782 |
| C peptide (ng/mL) | 0.909±0.49 | 0.940±0.49 | 0.599 |
| HOMA-IR | 2.40±1.37 | 2.38±1.34 | 0.874 |
| Total antioxidant capacity (nM) | 101.53±16.15 | 98.35±10.87 | 0.178 |
*Significant; p<0.05.
HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; LDL, low-density lipoprotein; RHI, Reactive Hyperemia Index; TC, total cholesterol.